Metylfenidat Teva (Methylphenidate Hydrochloride)

Methylphenidate blocks the reuptake of the neurotransmitters dopamine and norepinephrine at neuronal synapses, increasing their extracellular concentrations. The elevated levels enhance signaling in brain pathways that regulate attention, impulse control, and arousal, thereby improving focus and reducing fatigue in affected individuals.

The dosage of Metylfenidat Teva is individualized by the prescribing clinician based on the patient’s age, weight, severity of symptoms, and response to therapy. The prescriber determines the appropriate starting dose and any subsequent adjustments, following approved dosing guidelines for each indication.

Safety data for methylphenidate in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Metylfenidat Teva contains methylphenidate, a stimulant that directly increases dopamine and norepinephrine levels, whereas non‑stimulant options such as atomoxetine act by selectively inhibiting norepinephrine reuptake. Stimulants generally have a faster onset of action and may be more effective for core ADHD symptoms, but individual response and side‑effect profiles vary.

The product should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the medication out of reach of children and do not store it in bathrooms or other humid environments.

Metylfenidat Teva is taken orally, usually once or twice daily, as directed by the prescribing clinician. The tablets should be swallowed whole with water and can be taken with or without food, following the specific dosing schedule provided in the prescription.

Serious adverse events can include cardiovascular complications such as hypertension, arrhythmias, or myocardial infarction, as well as psychiatric effects like new or worsening psychosis, severe mood swings, or suicidal thoughts. Immediate medical attention is required if any of these symptoms occur.

The medication is contraindicated in individuals with known hypersensitivity to methylphenidate, those who have taken monoamine oxidase inhibitors within the past 14 days, patients with severe anxiety, agitation, glaucoma, or significant cardiovascular disease, and in anyone for whom a stimulant is deemed inappropriate by their healthcare provider.